Improving bone health by harnessing the anabolic potential of LDL receptor relate

通过利用 LDL 受体相关的合成代谢潜力来改善骨骼健康

• 批准号: 8245961
• 负责人: ALEXANDER G ROBLING
• 金额: --
• 依托单位: RLR VA MEDICAL CENTER
• 依托单位国家: 美国
• 财政年份: 2012
• 资助国家: 美国
• 起止时间: 2012-01-01 至 2015-12-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8245961
• 关键词: Accounting; Address; Affect; Age; Age-Years; Alcohol consumption; Alleles; American; Amino Acid Substitution; Anabolism; Binding; Biological; Bone Diseases; Bone Resorption; Bone Tissue; Collection; Data; Depressed mood; Diagnosis; Dioxins; Disease; Engineering; Environmental Risk Factor; Event; Family; Fracture; Genes; Goals; Hip Fractures; Human; Implant; Intervention; Knock-in Mouse; Knock-out; Knockout Mice; LDL-Receptor Related Protein 1; LDL-Receptor Related Proteins; Lead; Light; Long-Term Care; Low Density Lipoprotein Receptor; Mediating; Missense Mutation; Modeling; Molecular Target; Mus; Mutation; Orthopedics; Osteogenesis; Osteoporosis; Pathway interactions; Patients; Phenotype; Positioning Attribute; Post-Traumatic Stress Disorders; Predisposition; Prisoner; Prosthesis; Receptor Signaling; Regulation; Reporting; Research; Resistance; Risk; Services; Signal Pathway; Signal Transduction; Skeleton; Smoking; Specificity; Surface; Testing; Tetrachlorodibenzodioxin; Tissues; Veterans; Vietnam; WNT Signaling Pathway; War; Woman; adjudication; agent orange; bone; bone cell; bone health; bone loss; bone mass; bone metabolism; cell type; extracellular; improved; in vitro activity; in vivo; lifestyle factors; loss of function mutation; men; mortality; mouse model; novel; novel strategies; osteogenic; osteoporosis with pathological fracture; receptor; stem; tool; trafficking

DESCRIPTION (provided by applicant): Osteoporosis (porous bone disease) is a disease of the skeleton that can have debilitating effects on many US veterans. An estimated 44 million Americans, or 55 percent of the people 50 years of age and older, are currently at risk for osteoporotic fracture. Improved treatment options for the disease require a greater understanding of the cellular events and signaling pathways that control bone metabolism. The proposed research capitalizes on a collection of missense mutations in 2-propeller 1 of the LDL-receptor-related protein 5 (LRP5), recently identified in several human families, that have a major impact on bone mass regulation. The long term goal of the proposed project is to identify new molecular targets, yielded from novel mouse models engineered with those mutations, for pharmacologic intervention aimed at improving bone mass and reducing fracture susceptibility. LRP5 has been postulated to participate in the canonical WNT signaling cascade (e.g., GSK32-mediated modulation of 2- catenin activity) in vitro, but our recent data indicates that alterations in canonical WNT signaling might not account for the anabolic effects of the HBM mutations. Discovery of the mechanism by which Lrp5 controls bone formation would lead to new approaches for improving bone mass. In this application, we propose to determine whether 2-catenin is required for the bone formation effects of Lrp5. We will use two novel knock-in mouse models of HBM disease. These mice, which are modeled after two of the LRP5 HBM human families, have either the G171V or the A214V amino acid substitutions knocked in to Lrp5. The mutations result in very high bone mass, driven completely by increased bone formation, with no change in bone resorption. We will test whether these two mutations are associated with increased bone formation when 2- catenin is deleted. Further, we will determine whether the bone formation phenotype of Lrp5 knockout mice can be rescued by constitutive activation of 2-catenin. Subsequently, we will determine the mechanism of action for the G171V and A214V mutations, which appear to have fundamentally different effects at the cellular and tissue levels. In this Merit application, we address these questions in order to identify new Lrp5-associated anabolic targets for improving bone health. PUBLIC HEALTH RELEVANCE: Roughly 25% men over the age of 50 will suffer an osteoporotic fracture during their senior years, and the 1- year mortality rate following a hip fracture is nearly 2W as high for men as for women. One-fifth of those who were ambulatory before their hip fracture require long-term care afterward. Beyond their age, other lifestyle factors make veterans particularly susceptible to osteoporosis, including smoking, alcohol consumption, and an inactivity. Moreover, many Vietnam veterans were exposed to environmental factors during the war, such as the dioxin TCDD (found in Agent Orange), which put them at much greater risk for osteoporosis. Recently, the VA amended its adjudication regulation to establish a presumption of service connection for osteoporosis for former Prisoners of War (POWs) who were detained or interned for at least 30 days, and more recently, for those diagnosed with posttraumatic stress disorder (PTSD), and whose osteoporosis is at least 10% disabling. There is a clear need to identify new treatment options for veterans that suffer from low bone mass disease.

描述（由申请人提供）：